The question of why some people do not lose weight on tirzepatide usually comes down to dosage optimization, dietary factors, or metabolic considerations that can be addressed with protocol adjustments rather than compound switching
It typically peaks on days 2-4 and subsides as your body adapts
Furthermore, the number of neuron-derived orphan receptor 1 (NOR1) which can modulate VSMC proliferation, is decreased by GLP-1RAs in a dose-dependent manner in mice [121]
It is not intended for postmenopausal women or for treating low libido that stems from relationship problems, other medical conditions, or psychiatric issues
While peptide science itself is fascinating, clinical interest is not the same as clinical proof
Clinical trials show that Wegovy tablets have similar side effects to the injections